Mass HIway bolstered by $1.5M grant

The Massachusetts Technology Collaborative’s Massachusetts eHealth Institute (MeHI) will award $1.5 million in grant monies to EHR, clinical information system (CIS) and other care management system vendors to develop Direct Project-compliant interfaces for the interoperable exchange of health information in the commonwealth.

The MeHI and the state’s Executive Office of Health and Human Services launched the Mass HIway in 2012 to allow secure electronic information exchange between providers and organizations.

“The Meaningful Use program and secure exchange of electronic health records is key to delivering high-quality, cost-effective care,” said Pamela Goldberg, CEO of the Massachusetts Technology Collaborative. “These grants will support critical connections among providers in a variety of care settings to the HIway.”

The Mass HIway Interface Grant Program is open to any health IT vendor with four or more production implementations in Massachusetts.

“The grant is intended to provide an incentive to vendors whose products support providers in small practices or are used in settings not covered by the Meaningful Use incentives such as long-term care or behavior health; however, any EHR or CIS vendor is eligible and encouraged to apply,” according to the grant announcement.

Applications are due June 17. More information on the grant program is here.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.